Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer
about
Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Phase I/II Trial of Sorafenib ...... y for Metastatic Breast Cancer
@ast
Phase I/II Trial of Sorafenib ...... y for Metastatic Breast Cancer
@en
Phase I/II Trial of Sorafenib ...... y for Metastatic Breast Cancer
@nl
type
label
Phase I/II Trial of Sorafenib ...... y for Metastatic Breast Cancer
@ast
Phase I/II Trial of Sorafenib ...... y for Metastatic Breast Cancer
@en
Phase I/II Trial of Sorafenib ...... y for Metastatic Breast Cancer
@nl
prefLabel
Phase I/II Trial of Sorafenib ...... y for Metastatic Breast Cancer
@ast
Phase I/II Trial of Sorafenib ...... y for Metastatic Breast Cancer
@en
Phase I/II Trial of Sorafenib ...... y for Metastatic Breast Cancer
@nl
P2093
P2860
P921
P1433
P1476
Phase I/II Trial of Sorafenib ...... y for Metastatic Breast Cancer
@en
P2093
Adrian Langleben
Cristiano Ferrario
Emanuela Scarpi
Helen Charamis
Ivan Strepponi
Lawrence C Panasci
Wilson H Miller
P2860
P304
P356
10.1371/JOURNAL.PONE.0167906
P407
P577
2016-12-19T00:00:00Z